IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

WISAM A SALMAN

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1972706133
CMS profile
361926
Location
MARSHALL, MI

General Payments · PY2018–2024

$3,932.11

  • Reported across 157 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$907.06

56 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry MI All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $907.06 56

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Indivior Inc. $178.08 7
ABBVIE INC. $144.70 15
Alkermes, Inc. $143.11 10
Otsuka America Pharmaceutical, Inc. $101.77 6
Teva Pharmaceuticals USA, Inc. $89.14 5
Lundbeck LLC $83.19 4
ITI, Inc. $70.53 4
Neurocrine BioSciences, Inc. $40.40 2
E.R. Squibb & Sons, L.L.C. $24.79 1
Noven Therapeutics, LLC $15.88 1
Vanda Pharmaceuticals Inc. $15.47 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $697.42 28
PY2019 $376.67 13
PY2020 $275.03 4
PY2021 $397.07 10
PY2022 $646.31 18
PY2023 $632.55 28
PY2024 $907.06 56

Payment records · PY2024 (56)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $1.89 01/25/2024 Food and Beverage Undisputed 01/23/2026 1106007370 CMS
ABBVIE INC. $3.42 01/31/2024 Food and Beverage Undisputed 01/23/2026 1106007372 CMS
ABBVIE INC. $22.19 02/20/2024 Food and Beverage Undisputed 01/23/2026 1106007374 CMS
ABBVIE INC. $17.15 04/22/2024 Food and Beverage Undisputed 01/23/2026 1106007376 CMS
ABBVIE INC. $3.98 05/07/2024 Food and Beverage Undisputed 01/23/2026 1106007378 CMS
ABBVIE INC. $10.94 07/01/2024 Food and Beverage Undisputed 01/23/2026 1106007380 CMS
ABBVIE INC. $20.79 07/12/2024 Food and Beverage Undisputed 01/23/2026 1106007382 CMS
ABBVIE INC. $5.00 07/12/2024 Food and Beverage Undisputed 01/23/2026 1106007384 CMS
ABBVIE INC. $3.17 07/23/2024 Food and Beverage Undisputed 01/23/2026 1106007386 CMS
ABBVIE INC. $2.27 08/28/2024 Food and Beverage Undisputed 01/23/2026 1106007388 CMS
ABBVIE INC. $29.29 09/10/2024 Food and Beverage Undisputed 01/23/2026 1106007390 CMS
ABBVIE INC. $4.03 09/23/2024 Food and Beverage Undisputed 01/23/2026 1106007392 CMS
ABBVIE INC. $4.21 09/30/2024 Food and Beverage Undisputed 01/23/2026 1106007394 CMS
ABBVIE INC. $12.76 11/04/2024 Food and Beverage Undisputed 01/23/2026 1106007396 CMS
ABBVIE INC. $3.61 11/25/2024 Food and Beverage Undisputed 01/23/2026 1106007398 CMS
Alkermes, Inc. $11.76 01/08/2024 Food and Beverage Undisputed 01/23/2026 1120589108 CMS
Alkermes, Inc. $3.51 01/29/2024 Food and Beverage Undisputed 01/23/2026 1120589113 CMS
Alkermes, Inc. $20.63 02/22/2024 Food and Beverage Undisputed 01/23/2026 1120589116 CMS
Alkermes, Inc. $8.54 05/03/2024 Food and Beverage Undisputed 01/23/2026 1120589120 CMS
Alkermes, Inc. $11.28 07/18/2024 Food and Beverage Undisputed 01/23/2026 1120589124 CMS
Alkermes, Inc. $1.06 08/21/2024 Food and Beverage Undisputed 01/23/2026 1120589129 CMS
Alkermes, Inc. $10.14 08/21/2024 Food and Beverage Undisputed 01/23/2026 1120589133 CMS
Alkermes, Inc. $23.47 10/02/2024 Food and Beverage Undisputed 01/23/2026 1120589137 CMS
Alkermes, Inc. $23.32 11/12/2024 Food and Beverage Undisputed 01/23/2026 1120589140 CMS
Alkermes, Inc. $29.40 12/03/2024 Food and Beverage Undisputed 01/23/2026 1120589144 CMS
E.R. Squibb & Sons, L.L.C. $24.79 11/18/2024 Food and Beverage Undisputed 01/23/2026 1101222654 CMS
Indivior Inc. $23.78 01/23/2024 Food and Beverage Undisputed 01/23/2026 1144537398 CMS
Indivior Inc. $20.67 01/31/2024 Food and Beverage Undisputed 01/23/2026 1144537400 CMS
Indivior Inc. $44.50 04/26/2024 Food and Beverage Undisputed 01/23/2026 1144537402 CMS
Indivior Inc. $38.24 05/10/2024 Food and Beverage Undisputed 01/23/2026 1144537404 CMS
Indivior Inc. $15.00 05/10/2024 Food and Beverage Undisputed 01/23/2026 1144537406 CMS
Indivior Inc. $13.65 05/14/2024 Food and Beverage Undisputed 01/23/2026 1144537408 CMS
Indivior Inc. $22.24 07/30/2024 Food and Beverage Undisputed 01/23/2026 1144537410 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.46 04/23/2024 Food and Beverage Undisputed 01/23/2026 1143312632 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.11 05/06/2024 Food and Beverage Undisputed 01/23/2026 1143312636 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.80 06/07/2024 Food and Beverage Undisputed 01/23/2026 1143312640 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.16 07/19/2024 Food and Beverage Undisputed 01/23/2026 1143312643 CMS
Lundbeck LLC $21.11 02/02/2024 Food and Beverage Undisputed 01/23/2026 1145964690 CMS
Lundbeck LLC $15.72 07/23/2024 Food and Beverage Undisputed 01/23/2026 1145964692 CMS
Lundbeck LLC $25.71 07/29/2024 Food and Beverage Undisputed 01/23/2026 1145964694 CMS
Lundbeck LLC $20.65 08/22/2024 Food and Beverage Undisputed 01/23/2026 1145964696 CMS
Neurocrine Biosciences, Inc. $17.10 01/10/2024 Food and Beverage Undisputed 01/23/2026 1150868538 CMS
Neurocrine Biosciences, Inc. $23.30 05/06/2024 Food and Beverage Undisputed 01/23/2026 1150845481 CMS
Noven Therapeutics, LLC $15.88 04/30/2024 Food and Beverage Undisputed 01/23/2026 1084826747 CMS
Otsuka America Pharmaceutical, Inc. $20.35 02/23/2024 Food and Beverage Undisputed 01/23/2026 1118974988 CMS
Otsuka America Pharmaceutical, Inc. $16.75 05/21/2024 Food and Beverage Undisputed 01/23/2026 1118974990 CMS
Otsuka America Pharmaceutical, Inc. $16.96 08/02/2024 Food and Beverage Undisputed 01/23/2026 1118974992 CMS
Otsuka America Pharmaceutical, Inc. $15.74 10/11/2024 Food and Beverage Undisputed 01/23/2026 1118974994 CMS
Otsuka America Pharmaceutical, Inc. $14.82 10/18/2024 Food and Beverage Undisputed 01/23/2026 1118974996 CMS
Otsuka America Pharmaceutical, Inc. $17.15 11/25/2024 Food and Beverage Undisputed 01/23/2026 1118974998 CMS
Teva Pharmaceuticals USA, Inc. $22.19 04/26/2024 Food and Beverage Undisputed 01/23/2026 1151686567 CMS
Teva Pharmaceuticals USA, Inc. $16.56 06/24/2024 Food and Beverage Undisputed 01/23/2026 1151686604 CMS
Teva Pharmaceuticals USA, Inc. $19.08 07/16/2024 Food and Beverage Undisputed 01/23/2026 1151686636 CMS
Teva Pharmaceuticals USA, Inc. $15.87 08/15/2024 Food and Beverage Undisputed 01/23/2026 1151686655 CMS
Teva Pharmaceuticals USA, Inc. $15.44 09/09/2024 Food and Beverage Undisputed 01/23/2026 1151686920 CMS
Vanda Pharmaceuticals Inc. $15.47 08/09/2024 Food and Beverage Undisputed 01/23/2026 1133918943 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.